Thousands of leukaemia patients will benefit from a new treatment after health officials approved its use in the NHS. Patients in England with an incurable blood cancer will have access to acalabrutinib after it was approved by the National Institute for Health and Care Excellence.
Reproduced from today's i newspaper.
No smoke without fire
November 2020 Reading Rabbits 🐇📖
Completely fed up and not sure what to do next 
Hobbies during lockdown